| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 181517-13-5 | 5-Bromo-2,4-pyrimidinedione-13C,15N2 | C4H3BrN2O2 |
| 181525-38-2 | Paliperidone Impurity 5 | C11H12N2O3 |
| 181526-16-9 | Furo[2,3-b]Pyridine 7-Oxide | C7H5NO2 |
| 181526-18-1 | Furo[3,2-b]Pyridine 4-Oxide | C7H5NO2 |
| 181526-20-5 | Furo[2,3-c]Pyridine 6-Oxide | C7H5NO2 |
| 181526-31-8 | Furo[2,3-b]Pyridin-6(7H)-One | C7H5NO2 |
| 181526-33-0 | Furo[2,3-b]Pyridin-5-Ol | C7H5NO2 |
| 181528-64-3 | Artemether Tetrahydrofuran Acetate | C16H26O5 |
| 181530-09-6 | Zinquin Ethyl Ester | C21H22N2O5S |
| 181531-14-6 | Methyl 8-Chloro-6-(Trifluoromethyl)Imidazo[1,2-a]Pyridine-7-Carboxylate | C10H6ClF3N2O2 |
| 181531-25-9 | 4-Amino-5-Hydroxy-3-[(E)-(4-{[2-(Sulfooxy)Ethyl]Sulfonyl}Phenyl)Diazenyl]-2,7-Naphthalenedisulfonic Acid | C18H17N3O13S4 |
| 181576-27-2 | 1-Acetyl-2,6-dimethylpiperazine | C8H16N2O |
| 181581-82-8 | N-(2-Methylenebutyl)Benzamide | C12H15NO |
| 181585-85-3 | Methyl 1-Hydroxy-4-Nitro-1H-Pyrazole-3-Carboxylate | C5H5N3O5 |
| 181585-86-4 | Methyl 1-Hydroxy-3-Nitro-1H-Pyrazole-5-Carboxylate | C5H5N3O5 |
| 181585-88-6 | 1-Hydroxy-3-Nitro-1H-Pyrazole-4-Carbonitrile | C4H2N4O3 |
| 181585-93-3 | 5-Nitro-3-pyrazolecarboxylic acid methyl ester | C5H5N3O4 |
| 181586-74-3 | Dimethyl (2R,3R,5R,6R)-5,6-Dimethoxy-5,6-Dimethyl-1,4-Dioxane-2,3-Dicarboxylate | C12H20O8 |
| 181587-01-9 | Ethiprole | C13H9Cl2F3N4OS |
| 181589-32-2 | 3-Ethyl-5-Methyl-2-Vinylpyrazine | C9H12N2 |
| 181591-10-6 | 2-Deoxy-2-(sulfoamino)-4-O-(2-O-sulfo-alpha-D-idopyranuronosyl)-beta-D-glucopyranose 6-(hydrogen sulfate) | C12H21NO20S3 |
| 181629-03-8 | S,S,S-Tris(2-Ethylhexyl) Phosphorotrithioate | C24H51OPS3 |
| 181629-47-0 | 7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin Hydrochloride | C33H39ClN4O8 |
| 181629-57-2 | 2-Methyl-2-Propanyl 4-{[(Benzyloxy)Carbonyl][5-(Benzyloxy)-5-Oxopentyl]Amino}-1-Piperidinecarboxylate | C30H40N2O6 |
| 181629-93-6 | N-[3-Fluoro-5-(3-Pyridinyl)Phenyl]-5-Methoxy-6-(Trifluoromethyl)-1-Indolinecarboxamide | C22H17F4N3O2 |
| 181630-15-9 | Picoplatin | C6H7N.PtCl2.NH3 |
| 181632-25-7 | 6-Chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-pyridinyl]-1H-indole-1-carboxamide | C21H19ClN4O2 |
| 181636-84-0 | 3-(Tetrahydro-2H-Pyran-2-Yloxy)Propanamide | C8H15NO3 |
| 181640-72-2 | 5,11,17,23-TETRABROMO-25,26,27,28-TETRAPROPOXYCALIX[4]ARENE 98% | |
| 181646-38-8 | 2-Methyl-2-Propanyl (2-Methyl-4-Oxo-2-Butanyl)Carbamate | C10H19NO3 |
| 181647-06-3 | 4-[N-Ethyl-(4-methoxyphenyl)methylamino]-2-butynyl-1-ol | C14H19NO2 |
| 181647-10-9 | 4-[N-Ethyl-(4-methoxyphenyl)methylamino]-2-butynyl-2-cyclohexyl-2-hydroxybenzene Acetate | C28H35NO4 |
| 181647-12-1 | (R)-N-Desethyl Oxybutynin Hydrochloride | C20H28ClNO3 |
| 181647-14-3 | (S)-N-Desethyl Oxybutynin Hydrochloride | C20H28ClNO3 |
| 181647-19-8 | (alphaR)-alpha-Cyclohexyl-alpha-Hydroxy-Benzeneacetic Acid 4-(Ethylamino)-2-Butyn-1-Yl Ester | |
| 181647-45-0 | 6-Bromo-alpha-Phenyl-3-Pyridinemethanol | C12H10BrNO |
| 181647-47-2 | 2-[(Allylsulfanyl)Methyl]-5-Hydroxy-1-Methyl-4(1H)-Pyridinone | C10H13NO2S |
| 181647-50-7 | (5-Bromopyridin-2-Yl)-Phenylmethanol | C12H10BrNO |
| 181657-56-7 | (1R,2R)-(-)-2-Benzyloxycyclopentylamine | C12H17NO |
| 181657-57-8 | (1S,2S)-(+)-2-Benzyloxycyclopentylamine | C12H17NO |
| 181695-72-7 | Valdecoxib | C16H14N2O3S |
| 181695-81-8 | 1-Hydroxy Valdecoxib | C16H14N2O4S |
| 181695-84-1 | Parecoxib Impurity 43 | C16H14N2O3S |
| 181696-12-8 | Parecoxib Sulfonamide | C16H14N2O3S |
| 181696-35-5 | 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonic acid | C16H13NO4S |
| 181696-73-1 | 4,5-Dihydro-5-methyl-3,4-diphenyl-5-isoxazolol | C16H15NO2 |
| 181697-19-8 | 3-(4-Bromophenyl)-5-Methyl-4-Phenyl-1,2-Oxazole | C16H12BrNO |
| 181701-06-4 | Interiotherin A | C29H28O8 |
| 181701-30-4 | 2-(Trimethylsilyl)Ethyl 4-Oxo-1-Piperidinecarboxylate | C11H21NO3Si |
| 181702-77-2 | 4-Methoxyfluorophosphinyloxy-TEMPO | C10H20FNO4P |